Clinical trial
Comparison of Gastrointestinal Transit Measurements for the Atmo Capsule With Those of the Gold Standard (SmartPill) in Gastroparesis and Slow Transit Constipation Patients
NCT04977063 is registered in ClinicalTrials.gov with Atmo Biosciences Pty Ltd as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Comparison of Gastrointestinal Transit Measurements for the Atmo Capsule With Those of the Gold Standard (SmartPill) in Gastroparesis and Slow Transit Constipation Patients
- Lead sponsor
- Atmo Biosciences Pty Ltd
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- August 15, 2021
- Completion date
- March 15, 2023
- Enrollment
- 53 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
gastroparesis, slow transit